The resulting anemia is known as megaloblastic anemia and is the symptom for which the disease, pernicious anemia, was named (3)
BPC-157 is notably stable in gastric acid, unusual for a peptide
Thus, the specific contributions of GRK2 in angiogenesis and potential mechanisms therein, its integration in ECs and other cell types related to angiogenesis, and the expression and/or translocation changes that occur during disease development, need to be further confirmed
& Nelson, S
Researchers have safely applied these doses for up to two weeks based on the available case reports [6, 8, 14]
Phase II trials showed a good safety profile but didnt demonstrate weight-loss efficacy meaningfully better than placebo, which is why Metabolic Pharmaceuticals didnt pursue further regulatory approval